CORTEXA
← Browse
crossrefFrontiers in Pharmacology2026-07-10Cited by 0

Deciphering tuberculosis pathway mechanisms via graph neural networks and multimodal deep learning: a comprehensive AI-driven framework for precision medicine

Yuanli Yang, Huanqing Liu, Qian Lei, Tingting Li

Background Tuberculosis (TB) remains a global health crisis, with complex molecular mechanisms that are not fully understood. Traditional pathway analysis methods fail to capture the intricate non-linear relationships within biological networks. Methods We developed a novel artificial intelligence framework integrating graph neural networks (GNNs), transformer architectures, and multimodal deep learning to decipher TB pathway mechanisms. Our approach constructs a comprehensive pathway-gene interaction network from three critical pathways (Tuberculosis hsa05152, Antigen processing hsa04612, and NF-κB signaling hsa04064) and employs three interconnected models: (1) a Graph Convolutional Network for learning pathway-gene relationships, (2) a Transformer encoder for pathway activity prediction, and (3) a multimodal fusion model with attention mechanisms integrating transcriptomic, pathway, and clinical data. The framework was trained and validated on 467 clinical samples and 529 transcriptomic samples from five GEO datasets. Results The Transformer model achieved strong performance in pathway activity prediction ( R 2 = 0.97, MSE = 0.014), demonstrating high accuracy in capturing pathway activation patterns. The multimodal fusion model achieved strong predictive performance (accuracy 88.2%, AUC-ROC 0.90) in clinical outcome prediction, with attention analysis revealing adaptive weighting of different data modalities. Network analysis identified 27 shared genes between Tuberculosis and Antigen processing pathways, and 18 shared genes between Tuberculosis and NF-κB pathways, indicating coordinated immune regulation. Key pathway-gene interactions were identified, including critical roles of IFNG, TNF, IL1B, and NF-κB signaling components. Conclusion This study represents the first comprehensive application of GNNs and multimodal deep learning to TB pathway analysis. Our framework provides novel insights into TB pathogenesis, identifies potential therapeutic targets, and demonstrates the power of AI-driven approaches for understanding complex disease mechanisms. The interpretability of our models through attention mechanisms enables translation of computational findings into actionable biological insights, with significant implications for precision medicine and personalized TB treatment strategies.

View free PDFSource page

Related papers

crossrefFrontiers in Pharmacology2026-07-20

Integrating machine learning, deep learning, and docking to predict aristolochic acid A carcinogenesis

Longzhu Li, Jiacheng Liao, Xintian Chen, Zeqiong Lin, Siqiao Gong, Junmin Huang, et al.

Objective This study investigates the molecular mechanisms of renal clear cell carcinoma (RCC) induced by Aristolochic acid A (AAA) using machine learning, deep learning, and molecular docking approaches. Methods To identify AAA target genes associated with RCC, differential expr…

View free PDFSource page
openalexFrontiers in Pharmacology2026-07-23

Polyphyllin II attenuates renal fibrosis in diabetic kidney disease partly through regulation of autophagy and PI3K/AKT/mTOR signaling

Xia Sun, Xinfang Qin, Huixin Bi

Background Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease (ESRD) worldwide, and renal fibrosis is a key pathological feature driving disease progression. Polyphyllin II (PPII), a steroidal saponin isolated from Rhizoma Paridis, has shown renoprotectiv…

View free PDFSource page
crossrefFrontiers in Pharmacology2026-07-06

Hybrid mechanistic–machine learning PK/PD models with digital biomarkers: from cage to clinic

Szczepan W. Baran, Stefano Gaburro

Background Pharmacometric PK/PD models remain central to dose selection for first-in-human studies, therapeutic drug monitoring, and animal-to-human extrapolation of exposure–response relationships, but modern datasets, including digital biomarkers from continuous monitoring, omi…

View free PDFSource page
openalexFrontiers in Pharmacology2026-07-24

Editorial: Increasing importance of patients-generated real world data for healthcare policy decisions about medicinal products: volume III

Wai Yee Choon, K C Lee, Paul Scuffham, Shu Chuen Li, David Bin-Chia Wu, Jeff J. Guo

Increasing importance of patient-generated real-world data for healthcare policy decisions about medicinal products: Volume III Real-world data (RWD) and the real-world evidence (RWE) derived from it have moved from the margins to the centre of decision-making about medicinal pro…

View free PDFSource page
openalexFrontiers in Pharmacology2026-07-23

In silico high-throughput screening system for INMT activators in prostate cancer therapy

Haoyuan Zheng, Cao S, Zhuoling Kong, Peng Xin, Jianbin Bi, Jianfeng Wang

Prostate cancer (PCa) is one of the leading causes of cancer-related mortality in men, with castration-resistant prostate cancer (CRPC) posing significant therapeutic challenges due to drug resistance mediated by the androgen receptor (AR) signaling pathway. Indolethylamine-N-met…

View free PDFSource page
openalexFrontiers in Pharmacology2026-07-24

Protective effects and possible mechanisms of matrine-type alkaloids (matrine and oxymatrine) in animal models of ulcerative colitis: a preclinical systematic review and meta-analysis

吕书晴, H W Yang, Shiying Wang, Jiahui Ye, S H. M. Huang, Linkun Cai

Background Matrine and oxymatrine are bioactive alkaloids from Sophora species with reported anti-inflammatory and antioxidant effects in ulcerative colitis (UC). However, their overall efficacy has not been systematically evaluated. Methods Databases including PubMed, EMBASE, We…

View free PDFSource page